Nutritional supplementation with Se/FO could serve as a potential modulator to improve the treatment efficacy of first-generation EGFR-TKI by regulating multiple targets in a non-EGFR mutant NSCLC tumor model. Here, EGFR is linked to non-small cell lung carcinoma.